GlobeOrgan is an AI-augmented, blockchain-anchored global platform that transforms organ donation from reactive post-mortem consent to proactive, informed pre-mortem declaration — multiplying the global organ supply while honouring every donor's dignity and autonomy.
Globally, fewer than 30% of families consent to organ donation when asked for the first time at a critically ill patient's bedside. But when individuals have made an informed, voluntary pre-mortem declaration, family acceptance rises to over 90%. GlobeOrgan shifts the paradigm from reactive to proactive.
Over 3–5 years of longitudinal health data, the AI identifies patients whose trajectories indicate elevated probability of critical deterioration. Patients are engaged sensitively through their treating physician — never directly by the platform.
Separate models for kidney (CKD→ESRD), liver (cirrhosis), heart failure, lung failure, and multi-organ failure.
Every AI output accompanied by SHAP values identifying top contributing features. No black-box decisions.
Raw patient data never leaves the hospital. Only model weight updates transmitted with differential privacy.
Every declaration is cryptographically anchored to Hyperledger Fabric — a permissioned blockchain operated by participating health ministries, WHO, and the platform. Tamper-evident, legally non-repudiable, and verifiable by any authorised party.
Full donation (all organs), selective (specific organs), exclusion-based, and conditional declarations supported.
Nominated guardian completes a mandatory 20-minute legal briefing. Role is to facilitate, never to override.
Mandatory yearly review. Declarations not reaffirmed in 24 months flagged as Pending Review.
Produces a ranked, medically valid, legally compliant allocation list within 60 seconds of organ availability. The system automatically identifies recipients from the waiting list database and hospital records — no manual selection, no human bias.
Eliminate ABO-incompatible and DSA-positive crossmatch recipients. Absolute contraindications — no exceptions.
MELD ≥35 for liver, UNOS Status 1A/1B for heart/lung. Life-or-death patients ranked first automatically.
0–6 antigen mismatch scoring. Zero-mismatch kidneys receive mandatory national first-priority allocation.
Heart: 4–6 hrs, Kidney: 24–36 hrs, Liver: 8–12 hrs. Transport time vs. viability window validated in real-time.
The system cannot be influenced, overridden, or bypassed for the misuse of organ transportation. Every allocation decision is algorithm-driven, multi-authority-approved, and immutably logged.
When a patient faces imminent death without transplant (Status 1A), the system triggers a Special Emergency Request requiring triple-authority approval: the treating hospital, the patient's transplant coordinator, and the government authority (NOTTO in India / UNOS in USA). No single entity can unilaterally approve.
No human operator can manually override the ranked recipient list. The matching engine uses objective, data-driven medical criteria only — blood type, HLA compatibility, MELD/PELD scores, urgency status, and waiting time. Personal, social, or economic factors play zero role.
Every allocation decision, every status change, every approval/rejection is logged to an immutable audit store with actor identity, timestamp, and before/after values. Audit logs are preserved for 25 years per medico-legal requirements. Any anomaly triggers automatic ethics committee notification.
Zero monetary value attached to any organ. Any attempt to attach financial terms is a platform violation triggering immediate suspension. Cross-border transfers require health ministry letter, diplomatic clearance, and INTERPOL notification for trafficking risk cases.
Registered within minutes of certification
6-stage algorithm in under 60 seconds
Hospital + Patient + Govt authority approval
Traffic-cleared route with GPS tracking
Surgery within viability window
Full chain-of-custody audit logged
India MVP
Full NOTTO/SOTTO/ROTTO integration. Declaration module. Guardian management. 50 transplant centres onboarded.
South Asia + Middle East
Sri Lanka, Bangladesh, Nepal, Saudi Arabia, UAE, Kuwait. Country-specific legal modules.
EU, UK, USA, Australia
EU Directive 2010/53/EU. UNOS/OPTN integration. UK opt-out system. Federated AI deployment.
Global
All nations with organ donation legislation. Rare organ global registry. WHO partnership. Cross-border coordination.
All claims cross-referenced against GlobeOrgan Requirements Documentation v1.0, WHO Guiding Principles, THOA 1994, and UNOS/OPTN policies:
HLA-A, B, C (Class I) and HLA-DR, DQ, DP (Class II) typing, 0–6 mismatch scoring, PRA/DSA virtual crossmatch — all confirmed against Transplantation Society (TTS) standards.
Brain-stem death recognition, Authorisation Committee for non-near-relatives, NOTTO/SOTTO/ROTTO allocation hierarchy, and commercial trade prohibition — all correctly referenced per the Act.
Istanbul Declaration alignment, WHO Guiding Principle 5 (prohibition of organ commercialisation), INTERPOL notification for cross-border trafficking risk — all confirmed.
Year 1 metrics (500+ centres, 50K+ declarations, 100K+ health profiles) are aspirational targets. Platform is in v1.0 pre-launch phase as of May 2026.
Heart 4–6 hrs, Liver 8–12 hrs, Kidney 24–36 hrs cold ischaemia times are consistent with published transplantation literature and ASTS guidelines.
30% family consent for first-time bedside requests and 90%+ acceptance with pre-mortem declarations are consistent with published research in transplantation ethics literature.
AI-powered. Blockchain-secured. Legally compliant. Tamper-proof. Join the movement to transform organ donation worldwide.